Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
D003176:Complement C3 / Q000502:physiology; D003182:Complement C5 / Q000502:physiology; D003183:Complement C6 / Q000502:physiology; D003184:Complement C7 / Q000502:physiology; D003185:Complement C8 / Q000502:physiology; D003186:Complement C9 / Q000502:physiology; D003165:Complement System Proteins / Q000502:physiology*; D006084:Graft Rejection; D006461:Hemolysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation; D011414:Properdin / Q000032:analysis; D012910:Snake Venoms / Q000494:pharmacology; D014184:Transplantation, Homologous; D015054:Zymosan / Q000494:pharmacology
D003176:Complement C3; D003182:Complement C5; D003183:Complement C6; D003184:Complement C7; D003185:Complement C8; D003186:Complement C9; D007136:Immunoglobulins; D012910:Snake Venoms; D011414:Properdin; D003165:Complement System Proteins; D015054:Zymosan